SciDev.Net

The PATH Malaria Vaccine Initiative has outlined its ambitions for the next generation of vaccines.

Millions of children are missing out on the fruits of an explosion in vaccine development because they are too difficult to reach.

The Thailand HIV vaccine trial reveals the human body's fighting response to the virus, a conference has heard, but many questions remain.

Excitement about the potential of a plant root extract to combat swine flu is brought down to earth by a pandemics expert.

Bangladeshi researchers say that the antibiotic tigecycline has potential use in combination with antimalarials such as artemisinin.

A Nobel Prize winner has called for global rollout of vaccines that protect against cervical cancer — a big killer in the developing world.

An affordable cholera vaccine candidate that meets WHO standards has shown to be safe and effective in clinical trials.

A second meeting of the African Network for Drugs and Diagnosis Innovation has cemented its plans for African health innovation.

The dearth of drugs for Chagas could be over as two organisations collaborate on testing on a new treatment.

A TB medication that harnesses nanotechnology to cut treatment time and eliminate side effects has won a prestigious award.

An experimental HIV vaccine trialled in Thailand has reduced infection rates for the first time, by almost a third.

South African researchers are probing the AIDS-fighting potential of local plants, signalling a new alliance with healers.

A round-up of the latest articles on genetic susceptibility to swine flu, the EpiFlu database, a single-dose intravenous drug, and more.

A new centre will marry academia and industry in an unprecedented partnership to develop vaccines for the poor.

A round-up of articles about Africa's inability to cope with swine flu, human behaviour's affect on virus spread, vaccine progress, and more.

A study in India has found that a cheap vaccine can prevent typhoid infection in pre-school children, dispelling doubts.

Brazil's strategy for tackling HIV/AIDS — including the production of generic drugs — is an example to the developing world, say researchers.

Testing is under way for microbicidal gels containing antiretroviral drugs that could inhibit HIV infection.

Africa's first home-grown HIV vaccines have started early-stage clinical trials in South Africa and the United States.

New drugs to fight schistosomiasis could be on the way now the genomes of two worms that cause the disease have been sequenced.